Reactions 1704, p299 - 2 Jun 2018 Eruptive pruritus, squamoproliferative lesions and keratoacanthoma: case report A 74-year-old man developed eruptive pruritus, keratoacanthoma and squamoproliferative lesions during treatment with pembrolizumab [dosage and route not stated] for metastatic melanoma. Subsequently, he received treatment with unspecified topical agents and acitretin [duration of treatment to reactions onset and outcomes not stated]. Author comment: "A review of the case of a 74 M who developed eruptive pruritus, lichenoid keratosis and squamoproliferative lesions." "Included is a review of the literate on the management of the cutaneous side effects of patients on [pembrolizumab] therapy." Rayner J, et al. Eruptive pruritus, squamoproliferative lesions and keratoacanthomas in a patient on pembrolizumab for metastatic melanoma-case report and literature review. Australasian Journal of Dermatology 59 (Suppl. 1): 98, May 2018. Available from: URL: http://doi.org/10.1111/ajd.17_12815 [abstract] - Australia 803323599 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud